Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
PMID 24112036
Although GLP-1 medications have transformed obesity treatment, there remains a significant need for rigorous data examining how these therapies affect fertility and reproductive function in this population. The RESTORE study is currently evaluating semaglutide treatment in girls and women with PMOS and obesity, with the overarching goal of determining whether weight loss and metabolic improvements can restore ovulation and improve reproductive outcomes
Cariou B
J Clin Med 8 Cararo JH, Streck EL, Schuck PF et al (2015) Carnosine and related peptides: therapeutic potential in age-related disorders
US$ 23.23
US$ 21.67
US$ 26.63
US$ 29.09
US$ 26.70
US$ 23.32
